Fifth Third Bancorp’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $51.8K | Sell |
706
-51
| -7% | -$3.74K | ﹤0.01% | 1392 |
|
2025
Q1 | $86.5K | Buy |
757
+139
| +22% | +$15.9K | ﹤0.01% | 1209 |
|
2024
Q4 | $31.1K | Sell |
618
-9
| -1% | -$454 | ﹤0.01% | 1576 |
|
2024
Q3 | $29K | Buy |
627
+59
| +10% | +$2.73K | ﹤0.01% | 1641 |
|
2024
Q2 | $18.5K | Buy |
568
+81
| +17% | +$2.63K | ﹤0.01% | 1741 |
|
2024
Q1 | $12.3K | Buy |
487
+20
| +4% | +$504 | ﹤0.01% | 1814 |
|
2023
Q4 | $15.2K | Hold |
467
| – | – | ﹤0.01% | 1852 |
|
2023
Q3 | $12.7K | Hold |
467
| – | – | ﹤0.01% | 1885 |
|
2023
Q2 | $10.4K | Hold |
467
| – | – | ﹤0.01% | 1970 |
|
2023
Q1 | $10.1K | Buy |
467
+147
| +46% | +$3.18K | ﹤0.01% | 2094 |
|
2022
Q4 | $6.5K | Sell |
320
-48
| -13% | -$975 | ﹤0.01% | 2105 |
|
2022
Q3 | $9K | Buy |
368
+83
| +29% | +$2.03K | ﹤0.01% | 1979 |
|
2022
Q2 | $7K | Sell |
285
-48
| -14% | -$1.18K | ﹤0.01% | 2120 |
|
2022
Q1 | $7K | Buy |
333
+204
| +158% | +$4.29K | ﹤0.01% | 2171 |
|
2021
Q4 | $3K | Buy |
129
+28
| +28% | +$651 | ﹤0.01% | 2473 |
|
2021
Q3 | $2K | Buy |
+101
| New | +$2K | ﹤0.01% | 2431 |
|
2021
Q2 | – | Sell |
-253
| Closed | -$6K | – | 2436 |
|
2021
Q1 | $6K | Buy |
+253
| New | +$6K | ﹤0.01% | 2139 |
|
2019
Q1 | – | Sell |
-24,832
| Closed | -$332K | – | 2170 |
|
2018
Q4 | $332K | Sell |
24,832
-16,620
| -40% | -$222K | ﹤0.01% | 723 |
|
2018
Q3 | $581K | Buy |
41,452
+9,701
| +31% | +$136K | ﹤0.01% | 645 |
|
2018
Q2 | $499K | Sell |
31,751
-1,460
| -4% | -$22.9K | ﹤0.01% | 690 |
|
2018
Q1 | $546K | Buy |
+33,211
| New | +$546K | ﹤0.01% | 660 |
|